Criteria for TNF-Targeted Therapy in Rheumatoid Arthritis
- 1 January 2001
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 61 (12) , 1711-1720
- https://doi.org/10.2165/00003495-200161120-00003
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2000
- Etanercept in Children with Polyarticular Juvenile Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trialThe Lancet, 1999
- Etanercept Therapy in Rheumatoid ArthritisAnnals of Internal Medicine, 1999
- Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trialThe Lancet, 1999
- Functional impairment and disability in early rheumatoid arthritis--development over 5 years.1995
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- Outcome in rheumatoid arthritis. A 1985 inception cohort study.1994
- AURANOFIN IMPROVES OUTCOME IN EARLY RHEUMATOID-ARTHRITIS - RESULTS FROM A 2-YEAR, DOUBLE-BLIND, PLACEBO CONTROLLED-STUDY1988